Stay updated on Pharmacokinetics Safety BI 695502 Healthy Subjects Clinical Trial
Sign up to get notified when there's something new on the Pharmacokinetics Safety BI 695502 Healthy Subjects Clinical Trial page.

Latest updates to the Pharmacokinetics Safety BI 695502 Healthy Subjects Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoChange DetectedThe record describes a completed Phase 1 study of BI 695502 versus bevacizumab in healthy male subjects, including its eligibility criteria, locations, study design, and outcomes. It also provides results-related dates, a publication, and study documents.SummaryDifference44%

- Check18 days agoChange DetectedThe footer revision label changed from v3.7.2 to v3.8.0, while the page continues to display a 403 Forbidden error.SummaryDifference0.2%

- Check25 days agoChange DetectedA site-wide NIH banner announces a terminology transition from “Artificial Intelligence” to “Super Intelligence” and links to updates and FAQs. The study record page continues to display a 403 error.SummaryDifference1%

- Check32 days agoChange DetectedThe footer revision identifier changes from v3.7.1 to v3.7.2.SummaryDifference0.2%

- Check39 days agoChange DetectedThe footer’s site revision label changes from v3.7.0 to v3.7.1; the page continues to display a 403 Forbidden error.SummaryDifference0.2%

- Check60 days agoChange DetectedThe page now renders a 403 Forbidden error instead of the study details, indicating restricted access and transforming the page into an error screen.SummaryDifference17%

Stay in the know with updates to Pharmacokinetics Safety BI 695502 Healthy Subjects Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pharmacokinetics Safety BI 695502 Healthy Subjects Clinical Trial page.